| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK16 EPHB4 CDK16 SLK CDC42BPA SAMD8 MTOR PDIK1L GRK7 POLE DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 PI4KAP2 TSSK3 NME4 GK5 EPHA1 CDK4 EPHB1 | 1.54e-12 | 938 | 81 | 23 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | STK16 EPHB4 CDK16 SLK CDC42BPA MTOR PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 PI4KAP2 TSSK3 NME4 GK5 EPHA1 CDK4 EPHB1 | 2.06e-12 | 764 | 81 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | STK16 EPHB4 CDK16 SLK CDC42BPA MTOR PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 2.43e-11 | 600 | 81 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK16 EPHB4 CDK16 SLK CDC42BPA MTOR PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 GK5 EPHA1 CDK4 EPHB1 | 4.32e-11 | 709 | 81 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | STK16 CDK16 SLK CDC42BPA MTOR PDIK1L DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 2.03e-10 | 363 | 81 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK16 CDK16 SLK CDC42BPA MTOR PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 2.88e-10 | 446 | 81 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.63e-05 | 2 | 81 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 5.95e-05 | 19 | 81 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.61e-04 | 5 | 81 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 2.93e-04 | 32 | 81 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.10e-04 | 145 | 81 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 3.37e-04 | 7 | 81 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 4.48e-04 | 8 | 81 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.04e-03 | 12 | 81 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.65e-03 | 15 | 81 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.65e-03 | 15 | 81 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 1.78e-03 | 59 | 81 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.34e-03 | 65 | 81 | 3 | GO:0004714 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | STK16 EPHB4 SLK MTOR GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 EPHA1 EPHB1 | 4.28e-12 | 228 | 80 | 13 | GO:0046777 |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 5.58e-07 | 125 | 80 | 7 | GO:0018210 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 5.66e-06 | 115 | 80 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 3.22e-05 | 156 | 80 | 6 | GO:0006639 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 3.46e-05 | 158 | 80 | 6 | GO:0006638 | |
| GeneOntologyBiologicalProcess | acylglycerol acyl-chain remodeling | 8.87e-05 | 4 | 80 | 2 | GO:0036155 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 1.05e-04 | 63 | 80 | 4 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 1.05e-04 | 63 | 80 | 4 | GO:0046463 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 2.21e-04 | 6 | 80 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 2.21e-04 | 6 | 80 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 2.21e-04 | 6 | 80 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 2.21e-04 | 6 | 80 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 2.57e-04 | 429 | 80 | 8 | GO:0046486 | |
| GeneOntologyBiologicalProcess | chemokine (C-X-C motif) ligand 12 signaling pathway | 3.08e-04 | 7 | 80 | 2 | GO:0038146 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 4.10e-04 | 8 | 80 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | maintenance of lens transparency | 4.10e-04 | 8 | 80 | 2 | GO:0036438 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 4.10e-04 | 8 | 80 | 2 | GO:0031204 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 1.36e-04 | 5 | 78 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 2.04e-04 | 6 | 78 | 2 | GO:0071256 | |
| MousePheno | increased circulating methylmalonic acid level | 5.98e-05 | 3 | 63 | 2 | MP:0030630 | |
| MousePheno | abnormal methylmalonic acid level | 5.98e-05 | 3 | 63 | 2 | MP:0030627 | |
| MousePheno | increased methylmalonic acid level | 5.98e-05 | 3 | 63 | 2 | MP:0030628 | |
| Domain | Protein_kinase_ATP_BS | EPHB4 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 4.07e-12 | 379 | 79 | 16 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | STK16 EPHB4 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 6.39e-12 | 459 | 79 | 17 | PS00107 |
| Domain | Kinase-like_dom | STK16 EPHB4 CDK16 SLK CDC42BPA MTOR PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 8.59e-12 | 542 | 79 | 18 | IPR011009 |
| Domain | Prot_kinase_dom | STK16 EPHB4 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 1.73e-11 | 489 | 79 | 17 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | STK16 EPHB4 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 EPHA1 CDK4 EPHB1 | 1.97e-11 | 493 | 79 | 17 | PS50011 |
| Domain | Ser/Thr_kinase_AS | STK16 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 2.73e-10 | 357 | 79 | 14 | IPR008271 |
| Domain | S_TKc | STK16 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 2.94e-10 | 359 | 79 | 14 | SM00220 |
| Domain | PROTEIN_KINASE_ST | STK16 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 3.27e-10 | 362 | 79 | 14 | PS00108 |
| Domain | Pkinase | STK16 CDK16 SLK CDC42BPA PDIK1L GRK7 DYRK1A MAP3K9 MAP3K10 IRAK1 STK39 OXSR1 TSSK3 CDK4 | 6.37e-10 | 381 | 79 | 14 | PF00069 |
| Domain | Plug_translocon | 1.77e-05 | 2 | 79 | 2 | PF10559 | |
| Domain | SecY_su_dom | 1.77e-05 | 2 | 79 | 2 | IPR023201 | |
| Domain | SecY | 1.77e-05 | 2 | 79 | 2 | PF00344 | |
| Domain | SECY_1 | 1.77e-05 | 2 | 79 | 2 | PS00755 | |
| Domain | SECY_2 | 1.77e-05 | 2 | 79 | 2 | PS00756 | |
| Domain | - | 1.77e-05 | 2 | 79 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 1.77e-05 | 2 | 79 | 2 | IPR019561 | |
| Domain | SecY_CS | 1.77e-05 | 2 | 79 | 2 | IPR030659 | |
| Domain | SecY/SEC61-alpha | 1.77e-05 | 2 | 79 | 2 | IPR002208 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.56e-05 | 14 | 79 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.56e-05 | 14 | 79 | 3 | PS00790 | |
| Domain | Eph_TM | 2.56e-05 | 14 | 79 | 3 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.56e-05 | 14 | 79 | 3 | IPR001426 | |
| Domain | EPH_lbd | 2.56e-05 | 14 | 79 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 2.56e-05 | 14 | 79 | 3 | PF01404 | |
| Domain | EphA2_TM | 2.56e-05 | 14 | 79 | 3 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.56e-05 | 14 | 79 | 3 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.56e-05 | 14 | 79 | 3 | IPR001090 | |
| Domain | EPH_LBD | 2.56e-05 | 14 | 79 | 3 | PS51550 | |
| Domain | Dpy19 | 1.05e-04 | 4 | 79 | 2 | PF10034 | |
| Domain | NtCtMGAM_N | 1.05e-04 | 4 | 79 | 2 | PF16863 | |
| Domain | MLK1/MLK2/MLK4 | 1.05e-04 | 4 | 79 | 2 | IPR016231 | |
| Domain | Gal_mutarotase_N | 1.05e-04 | 4 | 79 | 2 | IPR031727 | |
| Domain | Dpy-19/Dpy-19-like | 1.05e-04 | 4 | 79 | 2 | IPR018732 | |
| Domain | MAP3K10 | 1.05e-04 | 4 | 79 | 2 | IPR015785 | |
| Domain | Ephrin_rec_like | 1.57e-04 | 25 | 79 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.57e-04 | 25 | 79 | 3 | IPR011641 | |
| Domain | SAM_1 | 1.97e-04 | 68 | 79 | 4 | PF00536 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.62e-04 | 6 | 79 | 2 | IPR024678 | |
| Domain | OSR1_C | 2.62e-04 | 6 | 79 | 2 | PF12202 | |
| Domain | Glyco_hydro_31_AS | 2.62e-04 | 6 | 79 | 2 | IPR030458 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.98e-04 | 138 | 79 | 5 | IPR001245 | |
| Domain | Glyco_hydro_31 | 3.66e-04 | 7 | 79 | 2 | IPR000322 | |
| Domain | DAGAT | 3.66e-04 | 7 | 79 | 2 | PF03982 | |
| Domain | DAGAT | 3.66e-04 | 7 | 79 | 2 | IPR007130 | |
| Domain | Glyco_hydro_31 | 3.66e-04 | 7 | 79 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 3.66e-04 | 7 | 79 | 2 | PS00129 | |
| Domain | Trefoil | 4.87e-04 | 8 | 79 | 2 | PF00088 | |
| Domain | TyrKc | 5.28e-04 | 88 | 79 | 4 | SM00219 | |
| Domain | SAM | 5.28e-04 | 88 | 79 | 4 | SM00454 | |
| Domain | Tyr_kinase_cat_dom | 5.28e-04 | 88 | 79 | 4 | IPR020635 | |
| Domain | P_TREFOIL_2 | 6.24e-04 | 9 | 79 | 2 | PS51448 | |
| Domain | PD | 6.24e-04 | 9 | 79 | 2 | SM00018 | |
| Domain | SAM_DOMAIN | 7.05e-04 | 95 | 79 | 4 | PS50105 | |
| Domain | SAM | 7.62e-04 | 97 | 79 | 4 | IPR001660 | |
| Domain | - | 9.48e-04 | 11 | 79 | 2 | 4.10.110.10 | |
| Domain | - | 1.06e-03 | 106 | 79 | 4 | 1.10.150.50 | |
| Domain | P_trefoil_dom | 1.13e-03 | 12 | 79 | 2 | IPR000519 | |
| Domain | SAM/pointed | 1.53e-03 | 117 | 79 | 4 | IPR013761 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.00e-03 | 59 | 79 | 3 | IPR011043 | |
| Domain | Pkinase_Tyr | 2.19e-03 | 129 | 79 | 4 | PF07714 | |
| Domain | Gal_mutarotase_SF_dom | 2.31e-03 | 17 | 79 | 2 | IPR011013 | |
| Domain | BTB | 2.31e-03 | 131 | 79 | 4 | PF00651 | |
| Domain | RHO | 3.19e-03 | 20 | 79 | 2 | PS51420 | |
| Domain | Kelch_1 | 3.25e-03 | 70 | 79 | 3 | PF01344 | |
| Domain | Kelch_1 | 3.25e-03 | 70 | 79 | 3 | IPR006652 | |
| Domain | - | 3.66e-03 | 73 | 79 | 3 | 2.60.120.260 | |
| Pubmed | Negative regulation of the creatine transporter SLC6A8 by SPAK and OSR1. | 1.22e-08 | 3 | 81 | 3 | 25531585 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 2.20e-07 | 372 | 81 | 9 | 22939624 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | STAG1 MTOR POLE SMARCA1 CHD4 OXSR1 ZC3H7B SEC61A1 HCFC1 TOP2B CDK4 | 7.26e-07 | 704 | 81 | 11 | 29955894 |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 27782176 | ||
| Pubmed | 4.35e-06 | 14 | 81 | 3 | 26941654 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23034389 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18480044 | ||
| Pubmed | Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival. | 5.36e-06 | 2 | 81 | 2 | 24121831 | |
| Pubmed | The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. | 5.36e-06 | 2 | 81 | 2 | 11416147 | |
| Pubmed | Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals. | 5.36e-06 | 2 | 81 | 2 | 24191005 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17321610 | ||
| Pubmed | Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. | 5.36e-06 | 2 | 81 | 2 | 16382158 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 36044864 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28170089 | ||
| Pubmed | The Ste20 kinases SPAK and OSR1 travel between cells through exosomes. | 5.36e-06 | 2 | 81 | 2 | 27122160 | |
| Pubmed | SPAK and OSR1 Sensitive Cell Membrane Protein Abundance and Activity of KCNQ1/E1 K+ Channels. | 5.36e-06 | 2 | 81 | 2 | 26584301 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8477742 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8536694 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28685610 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24585383 | ||
| Pubmed | Role of the WNK-activated SPAK kinase in regulating blood pressure. | 5.36e-06 | 2 | 81 | 2 | 20091762 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20374941 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26673921 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24173353 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 8.08e-06 | 17 | 81 | 3 | 12217323 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 SLC6A8 CDC42BPA NUP85 MTOR POLE DYRK1A IRAK1 DEPDC5 KAZALD1 ZC3H7B HCFC1 | 9.37e-06 | 1105 | 81 | 12 | 35748872 |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 1.35e-05 | 20 | 81 | 3 | 11256076 | |
| Pubmed | 1.35e-05 | 20 | 81 | 3 | 9530499 | ||
| Pubmed | 1.35e-05 | 20 | 81 | 3 | 10207129 | ||
| Pubmed | 1.35e-05 | 20 | 81 | 3 | 9576626 | ||
| Pubmed | 1.57e-05 | 21 | 81 | 3 | 9267020 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.57e-05 | 21 | 81 | 3 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.57e-05 | 21 | 81 | 3 | 20112066 | |
| Pubmed | 1.57e-05 | 21 | 81 | 3 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.57e-05 | 21 | 81 | 3 | 10730216 | |
| Pubmed | Structures of the Human SPAK and OSR1 Conserved C-Terminal (CCT) Domains. | 1.60e-05 | 3 | 81 | 2 | 34726826 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26861815 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27068441 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25323061 | ||
| Pubmed | Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype. | 1.60e-05 | 3 | 81 | 2 | 18414056 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22684558 | ||
| Pubmed | SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner. | 1.60e-05 | 3 | 81 | 2 | 22977235 | |
| Pubmed | Molecular components of signal amplification in olfactory sensory cilia. | 1.60e-05 | 3 | 81 | 2 | 20231443 | |
| Pubmed | The Dictyostelium discoideum family of Rho-related proteins. | 1.60e-05 | 3 | 81 | 2 | 11222756 | |
| Pubmed | Completing the structural family portrait of the human EphB tyrosine kinase domains. | 1.60e-05 | 3 | 81 | 2 | 24677421 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16263722 | ||
| Pubmed | Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma. | 1.60e-05 | 3 | 81 | 2 | 30084835 | |
| Pubmed | OSR1 and SPAK cooperatively modulate Sertoli cell support of mouse spermatogenesis. | 1.60e-05 | 3 | 81 | 2 | 27853306 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18270262 | ||
| Pubmed | Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis. | 1.60e-05 | 3 | 81 | 2 | 27314390 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34230123 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15722342 | ||
| Pubmed | SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation. | 1.60e-05 | 3 | 81 | 2 | 24039833 | |
| Pubmed | STK39 is an independent risk factor for male hypertension in Han Chinese. | 1.60e-05 | 3 | 81 | 2 | 20889219 | |
| Pubmed | SPAK and OSR1 Sensitivity of Excitatory Amino Acid Transporter EAAT3. | 1.60e-05 | 3 | 81 | 2 | 26112741 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 30696953 | ||
| Pubmed | Identification of the WNK-SPAK/OSR1 signaling pathway in rodent and human lenses. | 1.60e-05 | 3 | 81 | 2 | 25515571 | |
| Pubmed | Up-Regulation of Intestinal Phosphate Transporter NaPi-IIb (SLC34A2) by the Kinases SPAK and OSR1. | 1.60e-05 | 3 | 81 | 2 | 26506223 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12426103 | ||
| Pubmed | SPAK and OSR1 kinases bind and phosphorylate the β2-Adrenergic receptor. | 1.60e-05 | 3 | 81 | 2 | 32828531 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 8195146 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19307180 | ||
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 2.08e-05 | 23 | 81 | 3 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 2.38e-05 | 24 | 81 | 3 | 16446123 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NUP85 STAG1 KDM5A POLE SMARCA1 DYRK1A CHD4 HCFC1 TOP2B SMYD2 | 3.03e-05 | 857 | 81 | 10 | 25609649 |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 15671038 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 21486947 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 23129351 | ||
| Pubmed | Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1. | 3.20e-05 | 4 | 81 | 2 | 26233565 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 25565204 | ||
| Pubmed | SPAK and OSR1 dependent down-regulation of murine renal outer medullary K channel ROMK1. | 3.20e-05 | 4 | 81 | 2 | 25322850 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 25362046 | ||
| Pubmed | The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. | 3.20e-05 | 4 | 81 | 2 | 10212142 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 16669787 | ||
| Pubmed | High-throughput mapping of a dynamic signaling network in mammalian cells. | 3.35e-05 | 260 | 81 | 6 | 15761153 | |
| Pubmed | 3.82e-05 | 28 | 81 | 3 | 18593464 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 18835386 | ||
| Pubmed | Sites of regulated phosphorylation that control K-Cl cotransporter activity. | 5.33e-05 | 5 | 81 | 2 | 19665974 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 38411613 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 19008908 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 8601034 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 18800028 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 24808538 | ||
| Pubmed | A SPAK isoform switch modulates renal salt transport and blood pressure. | 5.33e-05 | 5 | 81 | 2 | 21907141 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 9565615 | ||
| Pubmed | WNK kinases sense molecular crowding and rescue cell volume via phase separation. | 5.33e-05 | 5 | 81 | 2 | 36318922 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 33840455 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16537705 | ||
| Pubmed | Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. | 7.99e-05 | 6 | 81 | 2 | 21321328 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 16705175 | ||
| Pubmed | Synthesis of neutral ether lipid monoalkyl-diacylglycerol by lipid acyltransferases. | 7.99e-05 | 6 | 81 | 2 | 28420705 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 22709582 | ||
| Pubmed | MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases. | 7.99e-05 | 6 | 81 | 2 | 21423148 | |
| Pubmed | 8.54e-05 | 606 | 81 | 8 | 36538041 | ||
| Pubmed | 9.39e-05 | 101 | 81 | 4 | 9872452 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 8954633 | ||
| Pubmed | 1.31e-04 | 42 | 81 | 3 | 26876175 | ||
| Pubmed | 1.40e-04 | 43 | 81 | 3 | 26030138 | ||
| Pubmed | 1.40e-04 | 43 | 81 | 3 | 33472061 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 29275959 | ||
| Interaction | CDC37 interactions | EPHB4 HSP90AB4P MTOR PDIK1L GRK7 RHOBTB2 MAP3K10 IRAK1 SMYD2 EPHA1 CDK4 PLCE1 EPHB1 | 1.07e-06 | 645 | 78 | 13 | int:CDC37 |
| Interaction | FKBP5 interactions | EPHB4 NUP85 HSP90AB4P PDIK1L POLE IRAK1 HCFC1 TOP2B CDK4 PLCE1 | 4.35e-06 | 414 | 78 | 10 | int:FKBP5 |
| Interaction | HSP90AA1 interactions | RHOBTB1 HSP90AB4P MTOR PDIK1L GRK7 RHOBTB2 MAP3K9 MAP3K10 IRAK1 TSSK3 ZC3H7B HCFC1 SMYD2 EPHA1 CDK4 PLCE1 EPHB1 | 5.21e-06 | 1263 | 78 | 17 | int:HSP90AA1 |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 7.99e-06 | 14 | 52 | 3 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 1.19e-04 | 88 | 52 | 4 | 760 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 2.25e-04 | 8 | 52 | 2 | 1235 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.93e-04 | 134 | 52 | 4 | 861 | |
| GeneFamily | Rho family GTPases | 1.49e-03 | 20 | 52 | 2 | 390 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.15e-03 | 24 | 52 | 2 | 654 | |
| GeneFamily | Cyclin dependent kinases | 2.52e-03 | 26 | 52 | 2 | 496 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 185 | 81 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 1.17e-05 | 162 | 81 | 5 | e088e66aabc307dde5d2b9aa295c34ef68155b1a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 163 | 81 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-05 | 173 | 81 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 188 | 81 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.45e-05 | 189 | 81 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 193 | 81 | 5 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-05 | 194 | 81 | 5 | 2b61023a602d336ed0de174e9141046173db34e6 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.78e-05 | 194 | 81 | 5 | f2486b19ac52a48d19f80b38a5536bee3dad745b | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-05 | 196 | 81 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 197 | 81 | 5 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 3.14e-05 | 199 | 81 | 5 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| Computational | Response to DNA damage. | 1.27e-06 | 187 | 47 | 8 | MODULE_244 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A | 4.32e-06 | 187 | 80 | 7 | 1614_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.50e-06 | 194 | 80 | 7 | 3758_DN | |
| Disease | Metastatic melanoma | 7.64e-09 | 54 | 80 | 6 | C0278883 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 7.26e-06 | 2 | 80 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 6.66e-05 | 29 | 80 | 3 | EFO_0008009 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 7.39e-05 | 30 | 80 | 3 | C1868672 | |
| Disease | intellectual disability (is_implicated_in) | 7.39e-05 | 30 | 80 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 9.09e-05 | 268 | 80 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 2.51e-04 | 45 | 80 | 3 | C0278701 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 2.68e-04 | 46 | 80 | 3 | EFO_0005325, HP_0012735 | |
| Disease | 4-vinylphenol sulfate measurement | 3.22e-04 | 10 | 80 | 2 | EFO_0021149 | |
| Disease | optic cup area measurement | 4.80e-04 | 56 | 80 | 3 | EFO_0006940 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 8.50e-04 | 16 | 80 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Rolandic epilepsy | 8.50e-04 | 16 | 80 | 2 | Orphanet_1945 | |
| Disease | response to acetylsalicylate | 8.50e-04 | 16 | 80 | 2 | GO_1903492 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 1.20e-03 | 19 | 80 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | feeling nervous measurement | 1.73e-03 | 87 | 80 | 3 | EFO_0009597 | |
| Disease | neurotic disorder | 2.64e-03 | 101 | 80 | 3 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEPCMAEEVCSMSWY | 156 | Q6ZRH7 | |
| MWEVLSFGDKPYGEM | 816 | P21709 | |
| YGMPFSLMGDCARWE | 171 | P51690 | |
| MFTYGCTWEFGAMVN | 176 | P08910 | |
| CYKFWPGMMDELSEL | 536 | Q6ZPD9 | |
| MPYDLAIDMWSLGCI | 336 | Q13627 | |
| PAMVTLACMDTWVYE | 181 | Q8NG85 | |
| EVYSFGEMPWDLALM | 421 | Q86XR2 | |
| CWMAPEVMEQVRGYD | 191 | O95747 | |
| QMSCEMWDFDIYGDL | 176 | O75140 | |
| GIVMWEVMSFGERPY | 811 | P54762 | |
| YNCVIYGWDPTCMMG | 516 | O94952 | |
| KMYVFGGWVPLVMDD | 266 | P51610 | |
| MSAAGTYAWMAPEVI | 261 | Q02779 | |
| FGCEVFAYPMASIEW | 191 | Q96I82 | |
| YGIVMWEVMSFGERP | 806 | P54760 | |
| MCVRWMQLGAFYPFS | 1521 | Q2M2H8 | |
| WIMDSFDDLMPEYVG | 311 | Q58FF6 | |
| EMCVRWMQLGAFYPF | 1566 | O43451 | |
| YEMCVRWMQLGAFYP | 2461 | O43451 | |
| TWSSEEMVYPGGAMV | 4166 | Q9NYQ8 | |
| NQMYFDWGPGEMLVC | 21 | Q9BW27 | |
| PAMVTLACMDTWVYE | 181 | Q8NGY9 | |
| CYFPRSDSWVEMAMR | 441 | Q8IY47 | |
| WYSMEMAGIVCFTGA | 826 | Q07864 | |
| DMHFLDAICWFPMVY | 761 | Q6UVM3 | |
| DAICWFPMVYYMVGS | 766 | Q6UVM3 | |
| FLAFMIFMCWVGDVY | 136 | O95169 | |
| EFGAMYAWMLCVFTV | 606 | O94886 | |
| EVIIASWYCTFMGIM | 196 | Q6NUT2 | |
| EVPPWVMCRFYKVMD | 21 | P51617 | |
| MKVPWLYVGMCFSSF | 466 | P29375 | |
| MGEDSPVAMFSWYLD | 686 | Q7Z442 | |
| GMCTVRFWFYMIDPR | 1806 | Q5VYJ5 | |
| AWVAFACTFISGMMY | 146 | P54851 | |
| VEMYDPETDCWTFMA | 541 | O94889 | |
| WMPFLREYVMSTGAC | 146 | Q6E213 | |
| AIVCDVWYMPPMTRE | 361 | Q53EU6 | |
| TQIDMWGVGCIFYEM | 341 | Q00536 | |
| YATPVDMWSVGCIFA | 191 | P11802 | |
| WIPIVREYVMSMGVC | 146 | Q6ZPD8 | |
| TGDVAVEMMWKPAYD | 776 | Q6ZN28 | |
| MFGVPWPEDMECSRF | 116 | Q9NPG1 | |
| GLFDPYKMCWSGMIT | 221 | Q6ZS86 | |
| PVDWFAMGCSIYEMV | 371 | Q8WTQ7 | |
| MWAPDMYVVTYVGDK | 796 | Q14839 | |
| KMSAAGTYAWMAPEV | 306 | P80192 | |
| WDSMEEYTCMIPRDT | 1526 | P42345 | |
| QYEISFKVWMCGGEM | 341 | Q49A17 | |
| IGTPYWMAPEVVMCE | 191 | Q9H2G2 | |
| FGIMSSDSADPFYWM | 51 | Q9H9S3 | |
| DEMMPGEWDVCVTSY | 276 | P28370 | |
| TDVWSLGCVLYAMMF | 216 | O75716 | |
| FMWVYDEDVGMNCRE | 81 | Q02880 | |
| EVMMVGWSDSYTCEY | 541 | Q9BXR5 | |
| MPFSMVRTVESCWYF | 86 | Q96RI8 | |
| FAMTEVCGMILCYIW | 201 | Q96LT4 | |
| MQILSSWFPEEGYMG | 2091 | Q9P212 | |
| MADPWQECMDYAVTL | 1 | P29218 | |
| MSSGPVVAMVWEGYN | 101 | O00746 | |
| MCLFMAPFETYSTWA | 201 | O15218 | |
| WFVMDFCDGGDMNEY | 116 | Q8N165 | |
| SCDWMAAMFGGPFVE | 521 | Q9BYZ6 | |
| LMETMWTYNLAFCGP | 156 | Q8NGP6 | |
| WVYGADRFMDDIACM | 496 | P48029 | |
| SCEWMAAMFGGSFVE | 506 | O94844 | |
| LVWMPGVNDCDLLMY | 316 | Q9P2R6 | |
| EATPFKWFMEMCVQA | 496 | A4QPH2 | |
| WSLGVCMYEMLYGET | 266 | Q5VT25 | |
| PALEMMYVWNGFSIV | 536 | Q5VTQ0 | |
| IMYFVRTPCEWGMDA | 1936 | Q8N2C7 | |
| YVWYFEGICFSGIMM | 46 | Q96CE8 | |
| FGIMSSDSADPFYWM | 51 | P61619 | |
| GDVWSMGVVLYVMLC | 191 | Q96PN8 | |
| MALCSFMGLPWYVAA | 881 | Q9BY07 | |
| CIEEIGVWMKMYSDA | 311 | Q8WVM7 | |
| FYNETEDCPGMMLWR | 2326 | Q7Z7G8 | |
| WMFFVGLVCYMGTFP | 6 | A0A0U1RRN3 | |
| YCVSWMVSSGMPDFL | 301 | Q9NQZ5 | |
| AMGVCLYMQDWEGAL | 346 | Q9NRG4 | |
| PCWMAPEVMEQVRGY | 236 | Q9UEW8 | |
| DPLLYMTEWFMCAFS | 266 | Q9BXI6 | |
| MPTDYADIMMGYHCW | 831 | Q9UGR2 | |
| VADPWGGSYMMECLT | 421 | P22033 |